Recruiting

Suicide Intervention

Sponsor:

Children's Hospital Los Angeles

Code:

NCT06880809

Conditions

Suicide Prevention

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Accepted

Interventions

Bridge the Gap (BTG) - Black Youth Group

Study Details

Brief summary:

The goal of this clinical trial is to develop and preliminarily test a culturally adapted suicide intervention specifically for black youth. The main question it aims to answer:

-To evaluate the feasibility and acceptability of the group, as well as the preliminary efficacy of the group for decreasing suicidal thoughts and behaviors and increasing protective factors such as hope, positive ethnic identity, and family and peer support.

Participants will be asked to attend 10-week group intervention and complete pre-treatment and post-treatment assessment measures.

Conditions

Suicide Prevention

Study ID

NCT06880809

Start date

Jun 1, 2025

Status verified date

Apr, 2026

Completion date

Jun 1, 2027

Anticipated

Primary completion date

Jan 1, 2027

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 12 - 17

Healthy Volunteers: Accepted

Inclusion Criteria:

  • 12-17 years old
  • Identify as Black or African American or being of African descent
  • Have current suicidal ideation or suicidal ideation within the last 30 days
  • Have assent from the adolescent participant and consent from an individual's caregiver or guardian to participate.

Exclusion Criteria:

  • An active psychotic disorder or current psychosis symptoms
  • No history of suicide attempt(s) or suicide ideation in the past 30 days
  • Cognitive deficits or a medical condition diagnosed from a medical provider that precludes full understanding of study materials as assessed through an inability to complete the pre-treatment CAMS SSF \& SSP
  • Caregivers, guardians, and/or the patient refuse to participate.

Study Design

Enrollment

16 participants

Anticipated

Intervention Model

Single group

Primary purpose

Prevention

Interventions and Outcome Measures

Arms

experimental: Treatment Arm

Participants will complete a 10-week group and complete pre-treatment and post-treatment assessment measures.

Interventions

Bridge the Gap (BTG) - Black Youth Group

Participants will complete a group intervention, rooted in the Collaborative Assessment \& Management of Suicidality (CAMS) evidence-based model, driven by their own unique identification of suicide drivers.

Primary outcome measure

  • The Collaborative Assessment & Management of Suicidality - Suicide Status Form (SSF) [ Time Frame: From pre-treatment until 3 months post-treatment, approximately 23 weeks. ]
  • Ethnic Identity Scale (EIS) [ Time Frame: From baseline until 3 months post-treatment, approximately 22 weeks. ]
  • Living Ladder Scale [ Time Frame: From baseline until 3 months post-treatment, approximately 22 weeks. ]
  • Brief Suicide Cognitions Scale (B-SCS) [ Time Frame: From baseline until 3 months post-treatment, approximately 22 weeks. ]
  • Therapeutic Relationship Working Alliance Inventory, Short Revised (WAI-SR) [ Time Frame: From baseline until 3 months post-treatment, approximately 22 weeks. ]
  • Optimism and Hope Scale (OHS) [ Time Frame: From baseline until 3 months post-treatment, approximately 22 weeks. ]
  • Parent Readiness for Hospital Discharge Scale (RHDS) [ Time Frame: From baseline until 3 months post-treatment, approximately 22 weeks. ]
  • Group Cohesion Scale [ Time Frame: From baseline until the beginning of post-treatment, approximately 10 weeks. ]

Central Contacts and Locations

Central contacts

Locations

Children's Hospital Los Angeles

Recruiting

Los Angeles, California, United States, 90027

Contacts

Principal Investigator:

Tia Tyndal, Ph.D.

More Information

Sponsor

Children's Hospital Los Angeles

Last update posted

Apr 30, 2026

Last verified

Apr, 2026

Keywords

  • Suicide Prevention
  • Black Youth
  • Collaborative Assessment & Management of Suicidality (CAMS)
  • Group Intervention

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by Children's Hospital Los Angeles on 2026-04-30.